Treatment discontinuation
Study drug will be stopped immediately if there is a disease
recurrence confirmed by CT, histology or cytology.
In the event of an SAE related to study drug, the study
drug will be stopped immediately but patients will continue
to be followed up until 5 years after
randomisation.